News
HUBc, disigned campus of international excellence
Thus, the UB became the first and only general university of Spain which has two international excellence campuses. The UB, along with the UPC [Catalan Polithecnic University], also won this award last year with the Barcelona Knowledge Campus (BKC).HUBc Campus includes the Medicine campus of Barcelona Clinic Hospital, along with Sant Joan de Déu Hospital, […]
La Marató de TV3 finance four projects involving IDIBELL researchers
Four IDIBELL researchers are involved in projects funded by La Marató de TV3 2009, dedicated to rare diseases. They are Julian Ceron, research group of chemoresistance and predictors of response and stromal tumour, Victor Volpini, research group of Neurological Disorders and Neurogenetics, David Monk, head of the group of genomic imprinting and cancer, and Ethel Queralt, head Cell Cycle Group. Julián Cerón Madrigal Victor Volpini Bertran David Monk Ethelvina Queralt Badia
Manel Esteller bestowed with the World Health Summit Award
The IDIBELL researcher receives in Berlin the World Health Summit and Pfizer Award for Innovation in Biomedical Research Manel Esteller Profile
Researchers find a biomarker that predicts a good response to a new drug against breast cancer
Epigenetic inactivation of BRCA1 enhances the effect of PARP inhibitors in breast tumors Paper reference: